Matthew Loft

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Artificial intelligence measured 3D lumbosacral body composition and clinical outcomes in rectal cancer patients.

Artificial intelligence measured 3D lumbosacral body composition and clinical outcomes in rectal cancer patients.

Journal: ANZ journal of surgery

Published: August 15, 2024

Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi study.

Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 02, 2024

Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.

Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.

Journal: Internal medicine journal

Published: May 13, 2024

Early onset metastatic colorectal cancer in Australia.

Early onset metastatic colorectal cancer in Australia.

Journal: Cancer treatment and research communications

Published: December 12, 2023

Clinical application of circulating tumour DNA in colorectal cancer.

Clinical application of circulating tumour DNA in colorectal cancer.

Journal: The lancet. Gastroenterology & hepatology

Published: March 23, 2023

Emerging trends in the prediction of pathological tumour response in rectal cancer following neoadjuvant therapy.

Emerging trends in the prediction of pathological tumour response in rectal cancer following neoadjuvant therapy.

Journal: ANZ journal of surgery

Published: December 19, 2022

Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments.

Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments.

Journal: ANZ journal of surgery

Published: August 13, 2022

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.

Journal: Breast cancer research and treatment

Published: July 18, 2022

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities.

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities.

Journal: Cancers

Published: July 18, 2022

Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer.

Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer.

Journal: Internal medicine journal

Published: April 04, 2022

Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer.

Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer.

Journal: Asia-Pacific journal of clinical oncology

Published: March 17, 2022

Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.

Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.

Journal: Asia-Pacific journal of clinical oncology

Published: August 29, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026